MRI scan to predict outcomes in liver disease
Part of Digestive system clinical trials.
This study looks at MRI images taken as part of routine care to see if they can help predict future health problems in people with liver disease. If you already have an MRI scheduled for clinical reasons, this may help doctors better estimate risk over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You already have an MRI scheduled for routine clinical care
- You are willing to let the team review/evaluate your MRI images
- You have a diagnosis of liver disease
- You can complete any additional study steps the team requires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new MRI technique to look at blood flow and iron in the liver, without needing a biopsy. It tests how well this newer imaging method works in people with liver disease and in healthy volunteers, to help improve diagnosis and monitoring.
This study uses MRI imaging and computer modeling to better plan liver surgery and related liver treatments. It may help doctors predict circulation (blood flow) changes during surgery and choose safer surgical timing or approaches.
This study uses special MRI scans to better predict liver cancer risk in people with chronic liver disease. It may help doctors identify high-risk patients earlier and improve monitoring.
This study uses a special MRI scan to measure liver stiffness before surgery to remove liver tumors. The goal is to see if this scan can help predict surgical risks and improve outcomes for patients undergoing liver surgery.
This trial uses a special type of MRI scan to see if doctors can predict how well a liver cancer treatment (called TACE) will work for you. The scan may help doctors understand your treatment response better.
This study uses MRI scans to find “biomarkers,” or imaging clues, that may help predict how autoimmune liver conditions will progress in children and young adults. If you qualify, you may get MRI imaging to see whether it relates to future health outcomes.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.